NIH-funded research R01 grant

Investigating how nasal immunity and microbiome affect lung health in people with HIV

Official title: HIV-Associated Lung Disease: The Role of Nasal Mucosal Immunity and Microbiome

Funded at Univ of North Carolina Chapel Hill · NIH-11008374 · Data updated 2026-11-12

This study is looking at why people with HIV might have more lung problems and is exploring how the immune system in the nose and the germs that live there can help protect against lung infections, so if you have HIV, your participation could help find ways to improve lung health for you and others.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startAugust 15, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$648,939
NIH project number1R01HL176283-01
Project IDNIH-11008374 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV who may be experiencing or are at risk for chronic lung diseases.

Less likely to help

Patients who do not have HIV or those without any respiratory issues may not benefit from this research.

What this research studies

This research focuses on understanding why individuals living with HIV are more susceptible to chronic lung diseases. It examines the role of the nasal mucosal immune system and the microbiome in protecting against respiratory infections and their potential impact on lung health. By comparing the nasal immune environment and microbiome of people living with HIV to those without the virus, the study aims to identify specific changes that could lead to better management of lung diseases. Participants will undergo assessments to track these changes over time.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for preventing and treating lung diseases in people living with HIV.

How similar studies have gone: Previous research has shown promising results in understanding the role of the microbiome in respiratory health, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Drummond, Michael Bradley — Univ of North Carolina Chapel Hill
  • Study coordinator: Drummond, Michael Bradley

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.